Philips CEO Says Company Performs Well Across the World

The transcript discusses Philips' fourth quarter performance, highlighting revenue growth, order growth, and innovations. It covers the global economic outlook, with a focus on China, North America, and Europe. The discussion includes Philips' strategy on mergers and acquisitions, emphasizing R&D investments and digital pathology. The transcript concludes with Philips' investment in the US market and its balanced global strategy.

What was the context of the conversation regarding Davos and its impact on the global outlook?

What were the growth percentages reported for North America and Europe?

What innovations are mentioned that contribute to better patient outcomes?